Episode 31: 2022 AACE Nonalcoholic Fatty Liver Disease Clinical Practice Guideline. Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)
Nonalcoholic fatty liver disease (NAFLD) is a major public health problem that will only worsen in the future, as it is closely linked to the epidemics of obesity and type 2 diabetes mellitus. Given this link, endocrinologists and primary care physicians are in an ideal position to identify persons at risk to prevent the development of cirrhosis and comorbidities. Join endocrine expert Vin Tangpricha, M.D., Ph.D., as he interviews AACE Co-Chairs, guideline task force experts, Kenneth Cusi, MD, FACP, FACE, and Scott D. Isaacs, MD, FACP, FACE, about the newly released 2022 clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease, published in the May 2022 issue of Endocrine Practice (https://www.endocrinepractice.org/article/S1530-891X(22)00090-8/fulltext).
Listen to endocrine experts, Vinni Makin, MD, Joumana Chaiban, MD, and Ricardo Correa, MD, share their personal experiences about how they obtained a visa as international medical graduates and transitioned to practicing medicine in the United States. Key topics include visa requirements, how to...
For persons with diabetes, vaccinations have been shown to help them from contracting and experiencing more severe outcomes from preventable illnesses, such as influenza and Covid-19.
It is important for the endocrine care team to learn practical strategies for increasing vaccination rates for...